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Left ventricular hypertrophy is an important adaptive
response to chronic pressure or volume overload of the
left ventricle. The different types and the pathophysiol-
ogic mechanisms of the development of left ventricular
hypertrophy in various disease states are reviewed. De-
tection of left ventricular hypertrophy may be accom-
plished by electrocardiography and cardiac angiogra-
phy. Echocardiography, however, is the most accurate
noninvasive method to detect the presence and estimate
the severity of increased left ventricular mass. The clin-
ical significance of left ventricular hypertrophy and its
prognostic implications in several cardiac diseases as-
Left ventricular hypertrophy is an important adaptive mech-
anism that occurs in disorders associated with pressure or
volume overload of the left ventricle. The presence of left
ventricular hypertrophy is most accurately detected by echo-
cardiography and cardiac angiography, and has significant
implications with regard to the prognosis of the underlying
heart disease. Regression of left ventricular hypertrophy
may be possible after correction of its cause with medical
or surgical therapy. In this article, the pathophysiologic
mechanisms and the means of detection and clinical sig-
nificance of left ventricular hypertrophy are reviewed. In
addition, data are presented documenting regression of left
ventricular hypertrophy.
Definitions: Etiology of Left
Ventricular Hypertrophy
Hypertrophy of the cardiac muscle is defined as an in-
crease in the size of existing myocardial fibers in contrast
to hyperplasia, which implies an increase in the number of
myocardial cells by mitotic division. Left ventricular hy-
From the LikoffCardiovascular Institute. Hahnemann University, Phil-
adelphia. Pennsylvania. Manuscript received June 27, 1983; revised manu-
script received October 17. 1983. accepted October 21, 1983.
Address for reprints: Morris N. Kotler, MD. 230 North Broad Street.
Philadelphia. Pennsylvania 19102.
if) 1984 by the American College of Cardiology
sociated with hypertrophy are discussed. The critical
transition stage from adaptive, compensatory and re-
versible .left ventricular hypertrophy to "pathologic"
hypertrophy with impaired left ventricular contractility
and irreversible myocardial damage is yet unknown.
Recent data are presented that provide evidence of
regression of left ventricular hypertrophy after medical
treatment of patients with hypertension and after aortic
valve replacement in patients with aortic valve disease.
The clinical importance of regression of hypertrophy and
its effectson long-term prognosisremain to be determined.
pertrophy may be global (diffuse) when there is approxi-
mately equal thickening of all left ventricular walls, or re-
gional when one wall of the left ventricle (interventricular
septum or free wall) is disproportionately thickened as com-
pared with the other wall.
Global left ventricular hypertrophy. This type of hy-
pertrophy is categorized into two subtypes; concentric, when
the increase in left ventricular mass is associated with a
normal-sized left ventricle, and eccentric or "dilated" hy-
pertrophy, when the increase in left ventricular mass is
associated with a dilated left ventricle.
Concentric global left ventricular hypertrophy. This is
the most common type and is usually caused by chronic
pressure overload of the left ventricle (as in valvular, sub-
valvular or supravalvular aortic stenosis and in arterial hy-
pertension) (I) (Fig. I). Concentric hypertrophy may also
be observed in patients with acromegaly and athletes en-
gaged in isometric exercise for a prolonged time (for ex-
ample, weight lifters). An increase in left ventricular mass
and concentric hypertrophy may result from infiltrative dis-
orders involving the myocardium (for example, amyloid
heart disease, sarcoidosis, hemosiderosis); in this case, how-
ever, the increased mass is caused by fibrosis and myocardial
infiltration and does not represent true hypertrophy of the
myocardial fibers.
Eccentric or "dilated" hypertrophy. In contrast, eccen-
tric or "dilated" hypertrophy is found in conditions asso-
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Figure 1. Two-dimensional echocardiogram in parasternal short-
axis view demonstrating concentric hypertrophy of the left ven-
tricle (LV) due to chronic hypertension (left panel) and dispro-
portionate hypertrophy of the interventricular septum andanterior
wall of the left ventricle in hypertrophic cardiomyopathy (right
panel). RV = right ventricle.
ciated with volume overload of the left ventricle, such as
aortic and mitral regurgitation, ventricular septal defect,
arteriovenous fistula and chronic isotonic exercise (for ex-
ample, in long distance runners) (l). This type can also
occur in patients with congestive cardiomyopathy (idio-
pathic or ischemic) (2).
Regional left ventricular hypertrophy. This type of
hypertrophy most commonly involves the interventricular
septum. Disproportionate septal thickening is the usual find-
ing in the developing embryonic and fetal heart and it is
relatively common in normal neonates up to I year of age
and infants with congenital heart disease (3). In adults,
disproportionate septal thickening defined as a septal to free
wall thickness ratio of 1.3 or greater is characteristic of the
genetically determined hypertrophic cardiomyopathy (Fig.
1); it can also occur in about 10% of patients with various
acquired or congenital heart diseases (3). A septal to free
wall thickness ratio of 1.5 or greater, a definition advocated
by other investigators (4), will increase the specificity of
this finding in diagnosing hypertrophic cardiomyopathy at
the expense of decreasing sensitivity.
Isolated hypertrophy of the left ventricular free wall is
uncommon. Hypertrophy confined to only a portion of the
interventricular septum (localized or focal septal hypertro-
phy) or left ventricular free wall is also uncommon and
probably represents a variant of hypertrophic cardio-
myopathybest demonstrated by two-dimensional echocardi-
ography (3).
Table 1. Development of Left Ventricular Hypertrophy (hypothesis)
CONCENTRIC
HYPERTROPHY
Wall
Thickening
"""-
.....-
............. - .......
"ECCENTRIC
HYPERTROPHY
Primary Stimulus () ,------------- ,,,....... ...... ......
PRESSURE~ Increased ~ Increased .. Parallel Addition ..
OVERLOAD Systolic Pressure Systolic Stress of New Myofibrils ~
(+) ~"'-------
--
--
--
--'\
VOLUME ~ Increased ~ Increased ~ Series Addition ~ Chamber ....
OVERLOAD Diastolic Pressure Diastolic Of New Sarcomeres Enlargement""'"(-) ,, S~::s ~,'
Dotted lines indicate negative (-) and positive (+) feedback. (Adapted with permission from Grossman W. Cardiac hypertrophy: useful adaptation
or pathologic process? Am 1 Med 1980;69:576-84.) See text for discussion.
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Pathophysiology of Left
Ventricular Hypertrophy
Normal ventricular growth. Cardiac growth during fe-
tal life is accomplished mainly by an increase in the number
of myocytes (hyperplasia), stimulatedby hemodynamic and
possibly hormonal factors (norepinephrine, for example)
(5), After birth, mitotic division of myocytes progressively
decreases and finally ceases at 3 to 6 months of age (6),
Thereafter, cardiac growth is achieved only by enlargement
(hypertrophy) of myocardial cells within a virtuallyconstant
population of myocytes, culminating in a 20-fold increase
in human left ventricular weight from birth to adulthood
(6), Thus the normalleft ventricularmass ranges up to 141 g
in adult women and to 175 to 203 g in adult men, but may
reach 220 g in persons with large body size or those per-
forming excessive physical activity (1,7-9), Other poten-
tially importantfactors that influence normal left ventricular
mass include normal aging (10) and blood pressure varia-
bility within the normal range (II). The normal ratio of left
to right ventricular mass is approximately 3.6.
Patterns of left ventricular hypertrophy. Although an
increase of left ventricular mass above these normal limits
may be observedin infiltrative disordersof the myocardium,
left ventricular hypertrophy is the most common cause of
increase in myocardial weight. In the adult, left ventricular
hypertrophy more frequently develops as a response to
hemodynamic stimuli (chronic pressure or volume overload
of the left ventricle). The following hypothesis proposed by
Grossman et al. (5,12) attempts to explain the patterns of
left ventricular hypertrophy observed according to the type
of stimulus. According to the Laplace law, left ventricular
wall stress (wall tension per unit of cross-sectional area) is
directly proportional to the left ventricular pressure and
chamber radius (r) and is inversely proportional to the ven-
tricular wall thickness (h) (13).
Role of wall stress in ventricular hypertrophy. When
pressure overload is the primary stimulus to hypertrophy,
the increasedleft ventricularsystolicpressureand wall stress
result in the additionof new myofibrils in parallel, increased
wall thickness and concentric hypertrophy. The wall thick-
ening tends to return wall stress toward normal (negative
feedback arrow in Table I). In contrast, when volumeover-
load is the primary stimulus, the increased left ventricular
diastolic pressure and wall stress lead to addition of new
sarcomeres in series, fiber elongation and chamber enlarge-
ment. This progressive chamber enlargement will lead to
increased systolic wall stress (positive feedback arrow in
Table I), wall thickening and eccentric hypertrophy which
normalizes systolic stress. Left ventricular wall stress is an
important determinant of myocardial contractility (5), In
pressure overload of the left ventricle, the increase in wall
thickness compensates for the increased systolic pressure
and maintains a constant and normal left ventricular wall
stress, thusenablingthe left ventricleto eject a normalstroke
volume against a high resistance (14).
In volume overload of the left ventricle. there is a pro-
portional increase in left ventricularend-diastolic radiusand
wall thickness, thus maintaining a normal chamber ra-
dius/wail thickness ratio and allowing the left ventricle to
eject an augmented stroke volume against a normal or re-
ducedresistance(6). This constantrelationbetweenpressure
and the chamber radius/wall thickness ratio is maintained
in persons with a normal heart, trained athletes and many
patients with compensated valvular heart disease (13).
Role of exercise (physiologic hypertrophy). Exercise
is a well known stimulus for the normal or so-called phys-
iologic left ventricularhypertrophy. The cardiac adaptation
consists of concentric hypertrophy (pressure overload) in
athletes engaged in isometricexercise (weight lifters, wres-
tlers, shot putters) and eccentric hypertrophy (volume over-
load) in athletes engaged in isotonic exercise (long distance
runners, swimmers,basketballplayers)(15). The latterform
of hypertrophy mayalso be observed in the volumeoverload
state associated with normal pregnancy (16).
Appropriate compensatory versus inappropriate hy-
pertrophy. Left ventricular hypertrophy in patients with
chroniccompensated left ventricularpressure overload (due
to aortic stenosis or hypertension) or volume overload (due
to aortic or mitral regurgitation) is considered appropriate
and compensatory. In patients with compensated aortic ste-
nosis, the inverse wall thickness/chamber radius ratio has
been used to estimate the left ventricular systolic pressure
(17,18). Most patients with nonobstructive hypertrophic
cardiomyopathy have a normal left ventricularsystolic pres-
sure and the increased septal thickness constitutes inappro-
priate hypertrophy. Although acute total ischemia may re-
sult in lossof myocardial volume anddecreased wall thickness
(19), mild to moderate chronic ischemia (20) or hypoxia
may inducehypertrophy of the left ventricle. Finally, excess
thyroid hormone can result in moderate left ventricular hy-
pertrophyby either a direct effect of the hormoneor possibly
by secondary hemodynamic changes (I).
Clinical Implications of Left
Ventricular Hypertrophy
Prognosis. The degree of left ventricular hypertrophy
correlates closely with the duration and hemodynamic se-
verity of chroniccardiac disease. The heart does not possess
an unlimited ability to increaseits mass in responseto hemo-
dynamic stress; what determines that limit has not been
definitely established. Inadequate hypertrophy (insufficient
muscle mass relative to chamber volume) or inability of
hypertrophy to keep pace with the hemodynamic derange-
ment may lead to an increase in wall stress and an unfa-
vorable outcome. Thus, patients with idiopathic congestive
cardiomyopathy and inadequate hypertrophy for the degree
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of left ventricular dilation have a shorter survival (2 ,21) .
Similarly, patients with chronic aortic regurgitation and in-
adequate compensatory hypertrophy may have a worse prog-
nosis after aortic valve replacement (22). The prognostic
value of left ventricular hypertrophy in mitral valve disease
has not been defined.
Myocardial damage and depressed function. Severe
left ventricular hypertrophy may be associated with de-
pressed cardiac function and structural changes including
interstitial fibrosis and cellular degeneration (I). There is
no definite evidence that chronic pressure overload hyper-
trophy in human beings is associated with a depression in
myocardial contractility (5,14). Cardiac hypertrophy in ath-
letes is usually associated with normal systolic performance
(13). However, a subset of patients with aortic stenosis or
chronic hypertension may have reduced systolic myocardial
function at rest and many have decreased systolic functional
reserve during exercise (23,24) . This may be caused by
damage to left ventricular myocardium from long-standing
pressure overload and a high degree of wall stress , suben-
docardial ischemia, diminished inotropic reserve in older
pat ients or coincidental unrelated disea se (5). In addition ,
diastolic left ventricular dysfunction and decreased com-
pliance have also been demonstrated in patients with con-
centric hypertrophy or hypertrophic cardiomyopathy (25,26).
Thus, a higher incidence of operative mortality and per-
sistent postoperative left ventricular dysfunction has been
reported (1,27,28) in patients with aortic valve disea se
undergoing valve replacement when severe preoperative hy-
pertrophy is present (left ventricular mass >300 g in one
study) (27).
Electrocardiographic evidence of left ventricular hyper-
trophy is a major determinant of outcome and is usually
associated with unfavorable prognosis in patients with hy-
pertension or coronary artery disease (29 ,30). It is possible
that irreversible myocardial damage is present by the time
left ventricular hypertrophy is detected on the electrocar-
diogram. A weak but significant correlation has been re-
ported (31,32) between blood pressure and the degree of
left ventricular muscle hypertrophy in hypertensive patients
(31,32). Spontaneous variability of blood pressure and other
possible factors may partially explain this poor correlation
(33, 34). Hypertensive cardiac hypertrophy appears to be
more closely related to blood pressure during stressful sit-
uation s than to basal blood pressure (34). However, exactly
when compensatory (adaptive) hypertrophy becomes " path-
ologic" hypertrophy , implying irreversible myocardial
damage and impaired contractility , is unknown . The iden-
tificat ion of this transitional stage has important clinical
implications and will require exten sive investigation.
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CPT I
~ LVET Figure 2. Simultaneous electrocardiogram (ECG),phonocardiogram (apex low frequency lLFJ), carotid
pulse tracing(CPT) and M-mode echocardiogram from
a normal individual. Wall thickness is measuredby the
standard technique (ST) or Penn convention method.
In the Pennconvention method, endocardialechoes are
excluded from the interventricular septal (lYS) thick-
ness and left ventricular posterior wall (LYPW) thick-
ness, but included in left ventricular systolic (Os) and
diastolic (Dd) dimensions. See text for discussion.
LYET = left ventricular ejection time. (Reprinted from
Kotler MN, et al. [37] with permission.)
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Detection of Left Ventricular Hypertrophy
Physical examination, electrocardiogram and chest
roentgenogram. In some patients, physical examination
may detect a sustained left ventricular impulse that is pal-
pable in two or more intercostal spaces. The electrocardio-
gram is the most commonly used technique for the detection
of left ventricular hypertrophy. The electrocardiographic
criteria for left ventricular hypertrophy have a specificity of
approximately 95%, but a sensitivity of less than 60%. The
Romhilt-Estes point score is more sensitive than the So-
kolow-Lyon voltage criteria (35), and the precordial lead
voltage criteria are more sensitive than the limb lead criteria
(36). The chest roentgenogram is relatively inaccurate for
the diagnosis of left ventricular hypertrophy. A significant
proportion of asymptomatic patients with systemic hyper-
tension may have evidence of left ventricular hypertrophy
despite a normal physical examination, electrocardiogram
and chest roentgenogram (37).
M-mode echocardiography. Quantitative angiography
and echocardiography are the most accurate methods for the
detection of left ventricular hypertrophy and correlate well
with autopsy measurements of left ventricular mass (I). In
one study (32) of 234 asymptomatic subjects with mild to
moderate systemic hypertension, an abnormally increased
ventricular septal or posterobasal free wall thickness or both,
was found by M-mode echocardiography in 61% of the
hypertensive subjects, while less than 10% of them had an
abnormal electrocardiogram or abnormal chest X-ray film.
Some studies (4,38) indicate that the interventricular septum
is involved earlier and to a greater extent in the hypertrophic
process than is the left ventricular posterior free wall.
Measurements of ventricular wall thickness by M-mode
echocardiography can be made by the Penn convention
method which excludes endocardial echoes or by the stan-
dard convention method which includes endocardial echoes
in wall thickness (Fig. 2) (7,35). Both methods permit an
estimate of left ventricular mass by assuming that the ven-
tricle is ellipsoid during end-diastole; the internal volume
of the left ventricle is subtracted from the external volume
to determine the volume of the ventricular muscle (37). Left
ventricular mass is then calculated using a specific gravity
of ventricular muscle of 1.05 g/crrr' (Table 2). Devereux
and Reichek (39) found that the Penn convention method
provides a more accurate estimate of left ventricular mass
than does the standard method. Calculation of left ventric-
ular mass by M-mode echocardiography is a more sensitive
indicator of hypertrophy than measurement of septal and
posterior wall thickness, approaching a sensitivity and spec-
ificity of greater than 90% (7,35).
M-mode echocardiography has limitations in measuring
wall thickness and calculating left ventricular mass. Dif-
ficulties in defining septal and left ventricular posterior wall
endocardium and abnormal echoes caused by chordal struc-
tures in the right ventricle may result in inaccurate mea-
surements, significant interobserver variation and difficul-
ties in reproducibility (40,4I). In addition, a very large
spherical ventricle or a small elongated ventricle and the
presence of segmental left ventricular wall abnormalities
affect the accurate M-mode echocardiographic determina-
tion of left ventricular mass.
Two-dimensional echocardiography. This technique
is preferable and probably the method of choice for cal-
culation of left ventricular mass, especially in patients with
abnormal left ventricular geometry and segmental disease
(42). Several experimental mathematic models for quanti-
fying left ventricular mass by two-dimensional echocardi-
ography have been proposed with excellent correlation with
pathologic determinations of left ventricular mass (43-45).
Utilizing a short-axis and an apical four chamber or two
chamber view (Fig. 3), calculation of left ventricular volume
and mass can be performed using the Simpson's rule or
area-length method (Table 2) (42,46).
Table 2. Echocardiographic Measurements of Left Ventricular Hypertrophy
A. M-mode echocardiography
I. Muscle cross-sectional area (CSA) = 'IT ([LVDd + PWd + IVSd]l2)' - 'IT(LVDd/2)2 (Ref. 19)
2. Penn convention: LV mass (g) = 1.04 X 10-' x (LVDd + PWd + IVSd)' - (LVDd)' - 14 g (Ref. 39)
3. Standard convention: LV mass (g) = 0.77 X 10-' x (LVDd + PWd + IVSd)' - (LVDd)' + 2.4 g (Refs. 7,37)
B. Two-dimensional echocardiography
AnT Tn'
I. Simpson's rule method: LV volume = LI (n - I) AT + - + 'IT- (Ref. 46)
2 6
5
2. Area-length method: LV volume = (; x (Ap) x L (Refs. 42,46)
3. LV mass = 1.055 x (total LV volume - cavity LV volume)
All dimensions are given in millimeters. A = short-axis view area; IVSd = end-diastolic interventricular wall thickness; L = longest epicardial or
endocardial length of the left ventricle; LV = left ventricular; LVDd = end-diastolic left ventricular dimension; n = number of sections; p = papillary
muscle level; PWd = end-diastolic posterior wall thickness; T = thickness of each section.
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Figure 3. Two-dimensional echocardiographic measurements of
ventricular dimensions and wall thickness. A, Apical two chamber
view. B, Apical four chamber view. C, Parasternal short-axis view
at level of papillary muscle. The long-axis (L) of theleft ventricle
(LV) is best measured in the apical two chamber view (A) because
considerable foreshortening may occur in the apical four chamber
view (B). The anteroposterior minor axis (D 1) and short transverse
diameter (D2) as well as wall thickness (WT) can be calculated
from the parasternal short-axis view (C). The calibration scale is
the same in these views. Ao = aorta; LA = left atrium; RA =
right atrium; RV = right ventricle. (Reprinted from Kotler MN,
et al. [37] with permission).
Regression of Left Ventricular Hypertrophy
Experimental studies (1,47) have shown that regression
of left ventricularhypertrophy can occur, at least partially,
when the increasein left ventricularmass is moderate (rang-
ing from 25 to 50%). Studiesof athletes engaged in isotonic
exercise (6) indicate that modest degrees of left ventricular
hypertrophy are rapidly reversible during voluntary cessa-
tion of training. Although regression of global (pressure or
volumeoverload) left ventricularhypertrophyhas been dem-
onstrated in patients with heart disease, only limited data
are available regarding the significance of this regression,
its relation to myocardial dysfunction and its prognostic
implications.
Cardiomyopathy. Regression of myocardial cellular
hypertrophy associated with improvement in cardiac func-
tion has been shown in patients with idiopathic dilated car-
diomyopathy treated with vasodilators (48). Disproportion-
ate septal thickening in infantsof diabetic mothers regresses
within the first 12 monthsof life (49,50). Medical treatment
of hypertrophic cardiomyopathy has not been reported to
cause regressionof septalhypertrophy (51). Prolongedtreat-
ment of hypertrophic cardiomyopathy with high doses of
propranolol may rarely cause a decrease in the precordial
electrocardiographic lead voltage (52).
Hypertension. Experimental studieshave shown regres-
sion of left ventricularhypertrophy in rats with spontaneous
hypertension after antihypertensive therapy with methyl-
dopa and clonidine (53,54), captopril (55), hydrochloro-
thiazide (56) and beta-adrenergic blocking agents (56,57).
Several studies utilizing electrocardiographic and M-mode
echocardiographic methods have demonstrated that regres-
sion of hypertrophy can also occur in hypertensive patients
treatedwith variousantihypertensive agents (Table 3). Early
studies (58-60) showed that a significant reduction of
electrocardiographic voltage correlated with the successful
control of hypertension. The electrocardiographic voltage
criteria, however, depend on age, weight and distance of
the left ventriclefrom the chest wall (61,62) and, therefore,
do not allow accurate quantification of alterations of left
ventricular mass (63).
Schlant et al. (64), utilizing M-mode echocardiography,
reported that effective treatment of hypertension in 95 pa-
tients resulted in a 21% regression of left ventricular mass
index over a 5 year follow-up period. A smaller decrease
in left ventricular mass was observed as early as 1 month
after control of hypertension was achieved with hydro-
chlorothiazide or methyldopa, or both (65). The changes in
left ventricular posterior wall and interventricular septal
thickness maybe lessprominent, and the sequenceof regres-
sion is variable (64,65). Cohen et al. (66) observed that a
greater number of patients with a normal left ventricular
mass than with hypertrophy were receiving two or more
JACC Vol. 3. No.5
May 1984:1309-20
PANIDIS ET AL.
LEFf VENTRICULAR HYPERTROPHY
1315
antihypertensive drugs. Most studies (67-72) agree that
regression of left ventricular hypertrophy correlates with the
blood pressure control. Some studies (73,74), however, found
no correlation between adequate blood pressure control and
regression of hypertrophy during therapy with methyldopa
and attributed these changes to a direct effect of sympathetic
inhibition. Regression of hypertrophy, however, without a
concomitant decrease in blood pressure may not be bene-
ficial because it results in a high degree of wall stress by
decreasing the compensatory hypertrophy.
Role of specific antihypertensive drugs. Regression of
left ventricular hypertrophy was also achieved after control
of blood pressure with beta-adrenergic blocking agents such
as timolol (75) and atenolol (76). Treatment with hydro-
chlorothiazide may cause a decrease (71), increase or no
change in left ventricular wall thickness (77,78). It is pos-
sible that in patients treated with diuretic drugs or vasodi-
lators, the beneficial effects of the decrease in pressure on
cardiac muscle mass are offset by the drug-induced increases
in the activities of the renin system and sympathetic nervous
system, which may induce cardiac hypertrophy (79). Whether
specific antihypertensive drugs are more effective in pro-
ducing regression of left ventricular hypertrophy by direct
effects or by actual control of blood pressure remains to be
determined. Although the concomitant decrease in blood
pressure and left ventricular mass is desirable in patients
with hypertension, the long-terin beneficial effects of regres-
sion of left ventricular hypertrophy achieved with antihy-
pertensive agents are unknown.
Aortic valve disease. Aortic stenosis. We studied 10
patients aged 26 to 83 years (mean 58 ± 13) with isolated
aortic stenosis by M-mode echocardiography preopera-
tively, in the early postoperative period « 6 months) and
in the late postoperative period (6 to 84 months) after aortic
valve replacement (unpublished data). A significant de"
crease (approximately 34%) in left ventricular mass cal-
culated by the conventional method was observed only dur-
ing the late postoperative period (> 6 months) (Fig. 4). A
significant reduction of left ventricular posterior wall and
interventricular septal thickness was also found during the
late postoperative studies (Fig. 5). Similar changes have
been observed by other investigators (80) to occur at 6
months, while other studies (81) have demonstrated regres-
sion as early as 3 to 5 weeks after aortic valve replacement
for aortic stenosis (Table 4).
Aorticregurgitation. Although reduction in left ventric-
ular mass has been reported to occur in patients with chronic
aortic regurgitation treated with arterial vasodilators (82),
the long-term effect of these agents is unknown. Regression
of left ventricular hypertrophy has been shown in such pa-
Table 3. Reported Studies of Regression of Left Ventricular Hypertrophy in Hypertension
Reference Patients
(first author) (no.) Treatment Method Results Follow-up
Ibrahim (58) 50 Not given ECG t Voltage 9 yr
Poblete (60) 137 Combination (HCTZ, ECG t Voltage 2.9 yr
methyldopa, l3-blockers)
Schlant (64) 95 Not given Echo 21% t LVM 5 yr
Wollam (65) 29 HCTZ (7 pts): Echo, 12 to 16"k. t LVM 1 to 12 mo
methyldopa (6 pts); ECG
both (16 pts)
Sonotani (67) 34 Combination (HCTZ. Echo t IVS-PW, I to 2 yr
methyldopa, l3-blockers) t LV mass
Hill (68) 14 Not given Echo t IVS-PW 12 wk
Dunn (69) 22 Combination Echo t IVS-PW. 9 mo
t 19% LVM
Corea (70) 7 Methyldopa Echo t IVS·PW 16 to 18 mo
Reichek (71) 27 HCTZ (IS pts); Echo t IVS-PW, II mo
HCTZ, methyldopa (12 pts) 18% t LVM
Rowlands (72) 25 Combination Echo t LVM 12 ± 7 mo
Drayer (73) 23 HCTZ, methyldopa Echo t IVS·PW 4 wk
Fouad (74) II Methyldopa (2 pts): Echo 35% t LVM 9 mo
methyldopa, HCTZ (9 pts) (4 pts)
Rowlands (75) 9 Timolol Echo 10% t LVM 16 wk
Ibrahim (76) 17 Atenolol Echo 12% t LVM 8 wk
Drayer (77) 20 HCTZ Echo IVS t (9 pts), 6 wk
IVS i or-( II pts)
ECG = electrocardiogram; Echo = M-modeechocardiography; HCTZ = hydrochlorothiazide; IVS = interventricularseptum;LVM = left ventricular
mass; pts = number of patients; PW = posterior wall; - = unchanged; t = decreased; i = increased.
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tients undergoing aortic valve replacement by serial electro-
cardiographic studies (83). Studies of patients with chronic
aortic regurgitation by angiography or echocardiography
Figure 4. Schematic diagram showing regression of left ventric-
ular mass (LVM) determinedby M-modeechocardiography during
early « 6 months) and late (> 6 months) postoperative period
after aortic valve replacement in patients with aortic stenosis. NS
= not significant; P = probability.
r-----P<0.005---.....,
,......--NS~~P<0.025---,
(22,84-86) also demonstrated significant regression of hy-
pertrophy and improvement of indexes of myocardial con-
tractility in most patients 6 to 15 months after aortic valve
replacement (Table 4). However, in some patients with iso-
lated aortic regurgitation or mixed aortic stenosis and aortic
regurgitation, the increased left ventricular mass and the
abnormal left ventricular function persisted even after suc-
cessful aortic valve replacement (86-88).
Whether this difference in reversibility of left ventricular
hypertrophy and left ventricular dysfunction between pa-
tients with aortic stenosis and aortic regurgitation is real or
occurs as a result of differences in the methods employed
is uncertain. It is possible that severe aortic stenosis may
be present (or a shorter period of time before it produces
symptoms necessitating valve replacement, while patients
with aortic regurgitation are less symptomatic and surgery
is delayed for a longer time (88). Whether primary depres-
sion of myocardial contractility is greater and hypertrophy
is more detrimental to ventricular performance and, thus,
less reversible in patients with volume overload than pres-
sure overload of the left ventricle remains to be determined.
Limitations of studies showing regression of left ven-
tricular hypertrophy. Most of the studies demonstrating
regression of left ventricular hypertrophy in patients with
hypertension or aortic valve disease included only a small
number of patients and utilized M-mode echocardiography
to estimate left ventricular mass (Tables 3 and 4). M-mode
echocardiography has several limitations in measuring wall
thickness and estimating left ventricular mass, especially
when serial changes are assessed (41,63,89). Furthermore,
changes in left ventricular wall thickness, although statis-
tically significant, were in the range of I to 2 mm (69,71,73),
and ventricular mass usually decreased less than 20% in
patients treated for hypertension. Thus, conflicting results
have been reported concerning the relation of blood pressure
III
Late
Postoperative
II
Early
Postoperative
I
Preoperative
r
380.1 ±155.0
:I 350
~ 300
250
200
150
100
50
650
600
550
500
450
a 400
-
Table 4. Reported Studies of Regression of Left Ventricular Hypertrophy in Aortic Valve Disease
Reference Heart Patients
(first author) Disease (no.) Method % Decrease LVM Follow-up
Henry (80) AS 42 Angio, 15 6 mo
Echo
Cody (81) AS 12 Echo 35 3 to 5 wk
Own data AS 10 Echo 34 6t084mo
Carroll (83) AR 25 ECG ~ voltage 6 mo
Gaasch (22) AR 19 Echo 40 6 mo
Schuler (84) AR 16 Echo 37 15 (9 to 35) mo
Bodem (85) AR 33 Echo 36 6 mo
Carroll (86) AR 23 Echo 20 lO 28 % ~ CSA 9 to 12 mo
Schwartz (87) AS, AR, 23 Echo 24 to 43 6 mo
or both
Pantely (88) AS,AR 18 Angio 421046 15 to 20 mo
Kennedy (91) AS, AR, 24 Angio 32 19 mo
or both
Angio = angiography; AR = aortic regurgitation; AS = aortic stenosis; CSA = cross-sectional area; ECG = electrocardiogram; Echo = M-mode
echocardiography; LVM = left ventricular mass; ~ = decrease.
JACC Vol. 3, No.5
May 1984: I309-20
PANIDIS ET AL.
LEFf VENTRICULAR HYPERTROPHY
1317
control and regression of hypertrophy as well as the ability
of various antihypertensive drugs to induce regression (67-77).
Studies of aortic valve disease were performed at various
intervals and utilized different methods (Table 4).
Clinical significance of regression of left ventricular
hypertrophy. Experimental studies (90) showed that
regression of left ventricular mass after correction of a vol-
ume overload state is associated with normalization of ul-
trastructural myofiber morphologic features. However,
regression of left ventricular mass in patients after surgical
correction of pressure or volume overload of the left ven-
tricle due to aortic valve disease is usually partial, and does
not return to normal (Table 4) (80,85,86,91). Incomplete
regression may be caused by irreversible damage of some
myocardial elements (for example, fibrosis) or by the small
Figure 5. Serial M-mode echocardiographic studies from a patient
with aortic valve replacement for aortic stenosis during preoper-
ative (A), early postoperative « 6 months) (B) and late postop-
erative (> 6 months) period (C). A significant decrease in inter-
ventricular septum (lVS) and left ventricular posterior wall (LVPW)
thickness is evident during thelate postoperative period. LVID =
left ventricular internal dimension during diastole (d) and systole
(s).
residual gradient across the prosthetic aortic valve (80,81,84).
It is possible, however, that a further reduction in left ven-
tricular hypertrophy will occur in some patients if they con-
tinue to have normal prosthetic valve function over a longer
period of time.
The functional and clinical outcome of patients with or
without regression of left ventricular hypertrophy is also
speculative. Whether the patient with complete regression
has a better functional result and long-term prognosis than
does the patient with incomplete or no regression of hy-
pertrophy is not known. Persistent postoperative hypertro-
phy after aortic valve replacement may be associated with
persistent left ventricular dysfunction, while a gradual
regression of hypertrophy parallels improvement in left ven-
tricular function (86). Other studies (80,84), however, found
no preoperative or postoperative echocardiographic and
hemodynamic variables that could predict the irreversibility
of hypertrophy, persistence of left ventricular dysfunction
or outcome of these patients. Thus, regression of left ven-
tricular hypertrophy does not necessarily assure normaliza-
tion of left ventricular function, and failure of regression
does not necessarily mean that function is abnormal (6).
Further studies are needed to determine the degree and
type of left ventricular hypertrophy that constitute a "path-
ologic" irreversible state, as well as the functional conse-
----------- --
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quences of the regression of hypertrophy in the various
disease states. The results of these investigations may be
helpful in determining the timing of therapeutic interven-
tions, so that regression of left ventricular hypertrophy,
improvement of left ventricular function and prolongation
of life expectancy are accomplished.
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